2022-01-042023-01-312023-01-31false13826097EPPYNAKS LIMITED2023-10-0343210iso4217:GBPxbrli:pure138260972022-01-04138260972023-01-31138260972022-01-042023-01-31138260972022-01-03138260972022-01-03138260972022-01-032022-01-0313826097bus:Micro-entities2022-01-042023-01-3113826097bus:AuditExempt-NoAccountantsReport2022-01-042023-01-3113826097bus:FullAccounts2022-01-042023-01-3113826097bus:PrivateLimitedCompanyLtd2022-01-042023-01-3113826097core:WithinOneYear2023-01-3113826097core:AfterOneYear2023-01-3113826097core:WithinOneYear2022-01-0313826097core:AfterOneYear2022-01-0313826097dpl:CostSales2022-01-042023-01-3113826097dpl:AdministrativeExpenses2022-01-042023-01-3113826097dpl:DistributionCosts2022-01-042023-01-3113826097dpl:CostSales2022-01-032022-01-0313826097dpl:AdministrativeExpenses2022-01-032022-01-0313826097dpl:DistributionCosts2022-01-032022-01-0313826097core:WithinOneYear2023-01-3113826097core:AfterOneYear2023-01-3113826097core:WithinOneYear2022-01-0313826097core:AfterOneYear2022-01-0313826097core:WithinOneYear2022-01-042023-01-3113826097core:AfterOneYear2022-01-042023-01-3113826097bus:Director12022-01-042023-01-31

EPPYNAKS LIMITED

Registered Number
13826097
(England and Wales)

Unaudited Financial Statements for the Period ended
31 January 2023

EPPYNAKS LIMITED
Company Information
for the period from 4 January 2022 to 31 January 2023

Director

NAKANACAGI, Epi Drugulevu

Registered Address

86-90 Paul Street
London
EC2A 4NE

Registered Number

13826097 (England and Wales)
EPPYNAKS LIMITED
Balance Sheet as at
31 January 2023

2023
£

Assets
Current Assets501
501
Capital, Reserves and Liabilities
Capital and reserves(1,086)
Creditors amounts falling due within one year1,587
501
The financial statements were approved and authorised for issue by the Director on 3 October 2023, and are signed on its behalf by:
NAKANACAGI, Epi Drugulevu
Director
Registered Company No. 13826097